Aranesp® Monthly Preference Study - 2

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis

NCT05636891 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

NCT00750295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

NCT00863707 ·Status: COMPLETED ·Phase: PHASE4

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

NCT01054261 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

NCT01359579 ·Status: TERMINATED ·Phase: PHASE1

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

NCT07181135 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

NCT02894905 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

NCT05624723 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

NCT03612856 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

NCT03890770 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

NCT00596518 ·Status: COMPLETED ·Phase: PHASE1

A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

NCT07165015 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

NCT01452828 ·Status: COMPLETED ·Phase: PHASE1

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

NCT02753894 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects

NCT04958187 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

NCT02840812 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants

NCT04616677 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment

NCT05489614 ·Status: COMPLETED ·Phase: PHASE1

NI-0401 in Patients With Acute Renal Allograft Rejection

NCT00805909 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb

NCT01560884 ·Status: COMPLETED ·Phase: PHASE1

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

NCT01372826 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

NCT00733265 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy

NCT04663204 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients

NCT01435174 ·Status: COMPLETED ·Phase: PHASE4